SILGARD

This brand name is authorized in Estonia, Lithuania

Active ingredients

The drug SILGARD contains a combination of these active pharmaceutical ingredients (APIs):

1 L1 protein of human papillomavirus type 6 UNII 61746O90DY - HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN

Read about L1 protein of human papillomavirus type 6

2 L1 protein of human papillomavirus type 11 UNII Z845VHQ61P - HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN

Read about L1 protein of human papillomavirus type 11

3 L1 protein of human papillomavirus type 16 UNII 6LTE2DNX63 - HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN

Read about L1 protein of human papillomavirus type 16

4 L1 protein of human papillomavirus type 18 UNII J2D279PEM5 - HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN

Read about L1 protein of human papillomavirus type 18

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07BM01	Papillomavirus (human types 6, 11, 16, 18)	J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BM Papillomavirus vaccines
Discover more medicines within J07BM01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1261134, 1261145, 1261156, 1261167, 1261178, 1537916
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1030779, 1030780, 1030781, 1030782, 1030783, 1030784, 1030785, 1030786, 1030796, 1030797, 1030798, 1030799